Tag: Nivolumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Nivolumab

Outcomes With Perioperative Immunotherapy in Resectable NSCLC - The ASCO Post

Added to Collection on: 2025-07-14 16:01:58

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer treatments
Lung cancer
Cancer immunotherapy
Pembrolizumab
Atezolizumab
Non-small-cell lung cancer
Nivolumab
Adjuvant therapy
Neoadjuvant therapy
Treatment of lung cancer
Flatiron Health

Click the tags to see associated articles and topics

View Article Details
Patent Infringement: Delhi High Court Restrains Zydus From Manufacturing Biologic Similar ...

Added to Collection on: 2025-07-19 16:31:04

Tags for this article:

Pharmaceutical industry of Gujarat
Zydus Lifesciences
Patent law
Prior art
Patent
Nivolumab
Zydus Lifesciences Limited

Click the tags to see associated articles and topics

View Article Details
Doctor Raises Concerns Over Medical Cannabis Use With Cancer Treatment - Newsweek

Added to Collection on: 2025-07-25 15:12:20

Tags for this article:

Herbalism
Medicinal plants
Cannabis smoking
Cancer
Orphan drugs
Cancer immunotherapy
Medical cannabis
Cancer treatment
Effects of cannabis
Immunotherapy
Cannabis
Nivolumab
Ben Jansen

Click the tags to see associated articles and topics

View Article Details
Top advances of the year: Bladder cancer - PubMed

Added to Collection on: 2025-08-10 17:49:00

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Cancer treatments
Adjuvant therapy
Analgesics
Bladder cancer
Durvalumab
Transitional cell carcinoma
Checkpoint inhibitor
Pembrolizumab
Nivolumab

Click the tags to see associated articles and topics

View Article Details
BMY vs GSK: Biopharma Giants Face Off in the Market - AInvest

Added to Collection on: 2025-08-22 21:22:58

Tags for this article:

GSK plc
Pharmaceutical companies
Bristol-Myers Squibb
CureVac
Pharmaceutical industry
Nivolumab
GlaxoSmithKline (GSK)

Click the tags to see associated articles and topics

View Article Details
The "disruptive therapy" for cancer, China's innovative drug's "DeepSeek moment"! The core keyword

Added to Collection on: 2025-08-31 12:22:29

Tags for this article:

Clusters of differentiation
Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Immune system
Programmed cell death protein 1
Pembrolizumab
PD-L1
Merck & Co.
Nivolumab
Bispecific monoclonal antibody
Ivonescimab
China

Click the tags to see associated articles and topics

View Article Details
Immunotherapy for Hodgkin's lymphoma - MedicalNewsToday

Added to Collection on: 2025-09-01 16:57:32

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Nivolumab
Checkpoint inhibitor
Brentuximab vedotin
Hodgkin lymphoma
Pembrolizumab
Immunotherapy
Cancer treatment
Lymphoma
Passive antibody therapy
Hodgkin

Click the tags to see associated articles and topics

View Article Details
Replimune's Regulatory and Legal Risks Amid FDA Rejection of RP1 - AInvest

Added to Collection on: 2025-09-15 13:17:56

Tags for this article:

Antineoplastic drugs
Orphan drugs
Nivolumab
Food and Drug Administration
Immunotherapy
REPLIMUNE

Click the tags to see associated articles and topics

View Article Details
IRR Rates May Be Lower Than Expected in the Real World - Hematology Advisor

Added to Collection on: 2025-09-18 13:48:19

Tags for this article:

Orphan drugs
Antineoplastic drugs
Nivolumab
Pembrolizumab
Atezolizumab
Ipilimumab
Monoclonal antibody
Pertuzumab
IRR
Durvalumab

Click the tags to see associated articles and topics

View Article Details
Peaks and valleys in bispecific antibody research - BioXconomy

Added to Collection on: 2025-10-01 15:56:19

Tags for this article:

Immune system
Immunology
Antineoplastic drugs
Cancer immunotherapy
Orphan drugs
Pembrolizumab
Monoclonal antibody therapy
Checkpoint inhibitor
Nivolumab
Ipilimumab
Antibody-drug conjugate
Monoclonal antibody

Click the tags to see associated articles and topics

View Article Details
Book a Demo